We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALM icon
1976
Cal-Maine
CALM
$4.42B
$10K ﹤0.01%
254
+127
+100% +$5.29K
COHU icon
1977
Cohu
COHU
$2B
$10K ﹤0.01%
448
-96
-18% -$1.72K
DBEU icon
1978
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$771M
$10K ﹤0.01%
333
-8,149
-96% -$247K
DEA
1979
Easterly Government Properties
DEA
$1.17B
$10K ﹤0.01%
176
+75
+74% +$4.23K
FISI icon
1980
Financial Institutions
FISI
$830M
$10K ﹤0.01%
344
– –
HCC icon
1981
Warrior Met Coal
HCC
$4.17B
$10K ﹤0.01%
517
+182
+54% +$3.72K
HSTM icon
1982
HealthStream
HSTM
$843M
$10K ﹤0.01%
428
+126
+42% +$3.47K
IYH icon
1983
iShares US Healthcare ETF
IYH
$3.46B
$10K ﹤0.01%
250
– –
JRVR icon
1984
James River Group Holdings
JRVR
$221M
$10K ﹤0.01%
245
+119
+94% +$4.67K
MGNX icon
1985
MacroGenics
MGNX
$245M
$10K ﹤0.01%
957
+172
+22% +$1.7K
MOMO
1986
Hello Group
MOMO
$869M
$10K ﹤0.01%
311
– –
MXL icon
1987
MaxLinear
MXL
$5.35B
$10K ﹤0.01%
495
-563
-53% -$11.7K
NWL icon
1988
Newell Brands
NWL
$2.24B
$10K ﹤0.01%
542
+301
+125% +$5.8K
PLAB icon
1989
Photronics
PLAB
$1.72B
$10K ﹤0.01%
678
+246
+57% +$3.1K
QCRH icon
1990
QCR Holdings
QCRH
$1.69B
$10K ﹤0.01%
235
+126
+116% +$5.15K
RWX icon
1991
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$10K ﹤0.01%
280
– –
SCHM icon
1992
Schwab US Mid-Cap ETF
SCHM
$14.5B
$10K ﹤0.01%
540
-4,152
-88% -$80.4K
STAG icon
1993
STAG Industrial
STAG
$7.79B
$10K ﹤0.01%
322
– –
TKC icon
1994
Turkcell
TKC
$4.78B
$10K ﹤0.01%
1,749
– –
TMHC icon
1995
Taylor Morrison
TMHC
$10K ﹤0.01%
516
+505
+4,591% +$12.1K
USPH icon
1996
US Physical Therapy
USPH
$1.2B
$10K ﹤0.01%
91
+38
+72% +$4.73K
VCYT icon
1997
Veracyte
VCYT
$4.44B
$10K ﹤0.01%
+377
New +$9.76K
WB icon
1998
Weibo
WB
$1.95B
$10K ﹤0.01%
222
– –
VGR
1999
DELISTED
Vector Group Ltd.
VGR
$10K ﹤0.01%
1,072
+450
+72% +$3.94K
ASXC
2000
DELISTED
Asensus Surgical, Inc.
ASXC
$10K ﹤0.01%
7,172
– –
78 79
80
81 82

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.